Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening. (3rd August 2021)

• Record Type: Journal Article
• Authors: Sobanski, Thais; Arantes, Lidia Maria Rebolho Batista; dos Santos, Wellington; Matsushita, Marcus; de Oliveira, Marco Antonio; Costa, Maraisa; de Carvalho, Ana Carolina; Berardinelli, Gustavo Noriz; Syrjänen, Kari; Reis, Rui Manuel; Guimarães, Denise Peixoto
• Is Part Of: Scandinavian journal of gastroenterology. Volume 56:Number 8(2021)
• Page Start: 920
• Page End: 928
• Publication Date: 2021-08-03
• Subjects: Colorectal cancer -- adenoma -- serrated polyps -- DNA methylation -- biomarker -- Brazil; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; 616.33
• DOI: 10.1080/00365521.2021.1922744
• Languages: English
• ISSNs: 0036-5521

Abstract

Abstract: Aims: Epigenetic alterations of genes involved in colorectal carcinogenesis are likely to be informative biomarkers for early detection. We assessed the methylation profile of a panel of seven colon cancer-related genes comparing normal colon, colorectal cancer (CRC) precursor lesions and cancer tissues from a Brazilian cohort. Methods: The cohort comprised 114 CRC patients, including 40 matched normal tissue, 47 patients with adenomas, 33 with serrated polyps and 8 with normal colonic biopsy. DNA methylation status of SEPT9, ALX4, NDRG4, BMP3, APC, p16 and MLH1 was determined by pyrosequencing and correlated with clinicopathological features. Sensitivity, specificity, positive predictive value and negative predictive value were calculated for all genes using cancer endpoint. Results: The most frequently methylated genes in cancer and in precancer lesions were SEPT9, ALX4, NDRG4, and BMP3, ranging from 55.3 to 95% of the samples. Overall, the frequency of methylation of these four genes in normal colonic tissue was significantly lower as compared to cancer or precursor lesions both in adenoma–carcinoma ( p < .001 and p < .050) and serrated (sessile-serrated lesion) ( p < .001 and p < .050) pathways. Additionally, sensitivity for the cancer endpoint ranged from 65.6 to 91.8%, and specificity from 17.9 to 62.9% for SEPT9, ALX4, NDRG4, and BMP3 genes. Moreover, the comethylation of ≥4 genes was higher in sessile-serrated lesion (87.5%) and conventional adenomas (78.7%) than in hyperplastic polyps (43.7%) ( p = .025) and was significantly associated with proximal cancers ( p = .042). Conclusions: Our study suggests the DNA methylation can constitute potential biomarkers in CRC screening of Brazilian population.